Cappell M S, Iacovone F M
Department of Medicine, Maimonides Medical Center, USA.
Am J Gastroenterol. 1996 Aug;91(8):1599-603.
To analyze the risks versus benefits of percutaneous endoscopic gastrostomy (PEG) performed soon after myocardial infarction.
Retrospective review of 28 patients undergoing PEG within 30 days after myocardial infarction at four university teaching hospitals for study periods of up to 10 yr. Forty controls undergoing PEG were matched for age and sex and had no myocardial infarction during the prior 6 months.
Indications for PEG were inability to eat because of stroke in 13, chronic dependency on mechanically assisted ventilation in seven, anoxic encephalopathy in five, dementia in two, and other in one. The mean patient age was 72.5 +/- 9.2 (SD) yr. PEG was performed on average 22.3 +/- 6.2 days after myocardial infarction. Seventeen patients were intubated and were receiving mechanically assisted ventilation at the time of PEG. PEG was successfully performed in all patients. Study patients suffered two insignificant complications, and one significant complication from PEG of bleeding at the gastrostomy site that required transfusion of 4 U of packed erythrocytes. Of note, no study patient suffered a cardiovascular complication due to PEG. The control complication rate was not significantly different (three insignificant and one significant complications, NS, Fisher's exact test). PEG feedings in study patients resulted in stabilization of body weight and significant improvement of the serum albumin level (from 2.2 +/- 0.3 gm/dl to 2.5 +/- 0.5 gm/dl, p < 0.03, Student's t test). Also the absolute lymphocyte count, hematocrit, and serum total protein level tended to improve after PEG. PEG contributed to transfer to a rehabilitation center, skilled nursing facility, or home in 19 study patients (70%; control rate = 78%, NS, chi 2).
Recent myocardial infarction is not an absolute contraindication to PEG. In this study, the benefits exceeded the risks of PEG in medically stable patients. PEG should be performed with monitoring by electrocardiography and pulse oximetry in medically stable patients. PEG is an elective procedure that should not be performed in highly unstable patients.
分析心肌梗死后不久行经皮内镜下胃造口术(PEG)的风险与获益。
回顾性分析4所大学教学医院在长达10年的研究期间内28例心肌梗死后30天内行PEG的患者。40例行PEG的对照者按年龄和性别匹配,且在之前6个月内无心肌梗死。
PEG的适应证为:因中风不能进食13例,长期依赖机械辅助通气7例,缺氧性脑病5例,痴呆2例,其他1例。患者平均年龄为72.5±9.2(标准差)岁。PEG平均在心肌梗死后22.3±6.2天进行。17例患者在PEG时已插管并接受机械辅助通气。所有患者PEG均成功完成。研究组患者发生2例轻微并发症,1例严重并发症为胃造口部位出血,需要输注4单位浓缩红细胞。值得注意的是,研究组患者均未因PEG发生心血管并发症。对照组并发症发生率无显著差异(3例轻微并发症和1例严重并发症,无显著性差异,Fisher精确检验)。研究组患者行PEG喂养后体重稳定,血清白蛋白水平显著改善(从2.2±0.3g/dl升至2.5±0.5g/dl,p<0.03,Student t检验)。PEG后绝对淋巴细胞计数、血细胞比容和血清总蛋白水平也有改善趋势。PEG促使19例研究组患者(70%)转至康复中心、专业护理机构或家中(对照组比例=78%,无显著性差异,卡方检验)。
近期心肌梗死并非PEG的绝对禁忌证。在本研究中,对于病情稳定的患者,PEG的获益超过风险。病情稳定的患者行PEG时应进行心电图和脉搏血氧饱和度监测。PEG是一项择期手术,高度不稳定的患者不应进行。